Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan

NCT02239380 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Status Epilepticus

Interventions

DRUG: Lorazepam

Sponsor

Pfizer